Adaptimmune Therapeutics PLC financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2025.

Location
Abingdon, Oxfordshire
Fiscal year end
31 December
Latest financial report
13 Aug 2025

Quick Takeaways

  • Adaptimmune Therapeutics PLC financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2025.
  • Headline metric: Return On Equity -1341%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+1962%</span>.
  • Most recent SEC facts end date: 11 Aug 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-08-11) highlights Return On Equity -1341.1%, Return On Assets -75.1%, and Operating Margin -252.3%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

23.6/100

Weak Confidence high

Return On Equity

-1341%

Metric score 0.0/100

Return On Assets

-75%

Metric score 0.0/100

Financial Health

Current Ratio
1.52x
Quick Ratio
0.69x
Debt to Equity
-52.49x

Strengths

Current Ratio and Quick Ratio

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-1341%

YoY: +1962%

Industry median: -47% (n=218)

View history

Return On Assets

-75%

YoY: +244%

Industry median: -44% (n=217)

View history

Operating Margin

-252%

YoY: +363%

Industry median: -263% (n=94)

View history

Current Ratio

1.52x

YoY: -51%

Industry median: 3.67x (n=218)

View history

Quick Ratio

0.69x

YoY: -74%

Industry median: 2.03x (n=83)

View history

Debt-to-equity

-52.49x

YoY: -1531%

Industry median: 0.31x (n=169)

View history

Revenues YoY

-54%

YoY:

Industry median: 11% (n=96)

View history

NetIncomeLoss YoY

-134%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -1341% +1962%
Return On Assets -75% +244%
Operating Margin -252% +363%

Financial Health

Metric Latest value YoY change
Current Ratio 1.52x -51%
Quick Ratio 0.69x -74%
Debt-to-equity -52.49x -1531%

Growth

Metric Latest value YoY change
Revenues YoY -54%
NetIncomeLoss YoY -134%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,590,309,546 +3.6%
Common Stock, Shares, Outstanding 1,590,309,546 +3.7%
Common Stock, Value, Issued $2,156,000 +3.5%
Weighted Average Number of Shares Outstanding, Basic 1,584,522,868 +3.3%
Weighted Average Number of Shares Outstanding, Diluted 1,584,522,868 +1.6%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $65,085,000 -54%
Research and Development Expense $125,241,000 -15%
Costs and Expenses $229,305,000 +4.9%
Operating Income (Loss) $164,220,000 -113%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $166,045,000 -133%
Income Tax Expense (Benefit) $3,711,000 +243%
Earnings Per Share, Basic 0 -140%
Earnings Per Share, Diluted 0 -83%
Cash and Cash Equivalents, at Carrying Value $26,061,000 -88%
Accounts Receivable, after Allowance for Credit Loss, Current $9,313,000 +299%
Inventory, Net $11,411,000
Other Assets, Current $3,516,000 +7%
Assets, Current $78,115,000 -69%
Property, Plant and Equipment, Net $28,152,000 -39%
Operating Lease, Right-of-Use Asset $18,748,000 +3%
Intangible Assets, Net (Excluding Goodwill) $3,807,000 +282%
Other Assets, Noncurrent $94,000
Assets $130,633,000 -59%
Accounts Payable, Current $9,418,000 +25%
Employee-related Liabilities, Current $7,594,000 -21%
Accrued Liabilities, Current $24,526,000 -20%
Contract with Customer, Liability, Current $10,700,000 -72%
Liabilities, Current $51,513,000 -37%
Contract with Customer, Liability, Noncurrent $101,419,000
Operating Lease, Liability, Noncurrent $18,491,000 +8.1%
Other Liabilities, Noncurrent $4,493,000 +212%
Liabilities $201,591,000 -11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $10,612,000 -211%
Retained Earnings (Accumulated Deficit) $1,171,911,000 -17%
Stockholders' Equity Attributable to Parent $70,958,000 -174%
Liabilities and Equity $130,633,000 -59%
Common Stock, Shares Authorized 2,108,130,546 +3.4%
Common Stock, Shares, Issued 1,590,309,546 +3.7%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27,778,000 -87%
Operating Lease, Liability $23,005,000 +2.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $176,956,000 -143%
Lessee, Operating Lease, Liability, to be Paid $29,845,000 +12%
Operating Lease, Liability, Current $4,514,000 -15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,391,000 -21%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,774,000 +40%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 +26%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,840,000 +64%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,443,000 +1.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,496,000 -19%
Additional Paid in Capital $1,109,409,000 +0.88%
Share-based Payment Arrangement, Expense $1,067,000 -109%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY